Optio Rx, LLC – Trademark Portfolio
Entity Type: 16
Optio Rx, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OPTIO RX and CRESTVIEW PHARMACY. The owner is based in Glenview, IL.
Suite 200
1247 Waukegan Rd.
Glenview, IL 60025
Showing of trademarks Trademarks
Trademark Classifications
Optio Rx, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Optio Rx, LLC have?
Optio Rx, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Optio Rx, LLC file in?
Optio Rx, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 36 (Insurance & Financial), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Optio Rx, LLC's most well-known trademarks?
Optio Rx, LLC's registered trademark portfolio includes well-known marks such as OPTIO RX and CRESTVIEW PHARMACY. These are among 2 currently registered trademarks in the portfolio.
What is Optio Rx, LLC's trademark registration success rate?
Optio Rx, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.